Application 204130
- Type
- ANDA
- Sponsor
- LUPIN LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FOSAMPRENAVIR CALCIUM | FOSAMPRENAVIR CALCIUM | TABLET;ORAL | 700MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fosamprenavir Calcium | FOSAMPRENAVIR CALCIUM | Sun Pharmaceutical Industries, Inc. | 5cd1eead-9fc1-426c-bee8-214ffa7d9dc1 | 2026-06-30 | Warnings, Adverse reactions | Fosamprenavir Calcium FOSAMPRENAVIR CALCIUM |
| Fosamprenavir Calcium | FOSAMPRENAVIR CALCIUM | Mylan Pharmaceuticals Inc. | 3a1424d8-844c-4e24-9ebd-b2c2b61b61a3 | 2023-09-15 | Warnings, Adverse reactions | Fosamprenavir Calcium FOSAMPRENAVIR CALCIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.